tiprankstipranks
Trending News
More News >
Medical Facilities Corp (TSE:DR)
:DR

Medical Facilities (DR) AI Stock Analysis

Compare
78 Followers

Top Page

TS

Medical Facilities

(OTC:DR)

Rating:73Outperform
Price Target:
C$17.50
▲(10.41%Upside)
The overall score reflects solid financial performance with strong profitability and operational efficiency. The company’s undervalued nature and proactive corporate actions, like share buybacks and dividends, further bolster its attractiveness. However, the lack of growth in revenue and free cash flow introduces some caution.

Medical Facilities (DR) vs. iShares MSCI Canada ETF (EWC)

Medical Facilities Business Overview & Revenue Model

Company DescriptionMedical Facilities Corporation (DR) is a healthcare services company that owns and operates a diverse portfolio of surgical facilities across the United States. The company focuses on providing high-quality, cost-effective healthcare services through its network of specialty surgical hospitals and ambulatory surgery centers. These facilities offer a wide range of surgical procedures, including orthopedics, neurosurgery, and pain management, catering to the growing demand for outpatient services.
How the Company Makes MoneyMedical Facilities Corporation generates revenue primarily through the provision of surgical services at its owned and operated facilities. The company's key revenue streams include payments from private health insurance providers, government healthcare programs like Medicare and Medicaid, and out-of-pocket payments from patients. The company also benefits from strategic partnerships with physicians and healthcare organizations, which help drive patient referrals and enhance operational efficiencies. Additionally, Medical Facilities Corporation focuses on optimizing its cost structure and expanding its service offerings to increase profitability and shareholder value.

Medical Facilities Earnings Call Summary

Earnings Call Date:May 08, 2025
(Q4-2024)
|
% Change Since: 4.55%|
Next Earnings Date:Aug 07, 2025
Earnings Call Sentiment Positive
The earnings call reflected a strong financial position due to strategic asset sales and effective cash management, with significant shareholder returns. However, the company faced challenges in revenue growth and incurred an impairment charge, indicating areas for improvement.
Q4-2024 Updates
Positive Updates
Sale of Black Hills to Sanford Health
MFC completed the sale of Black Hills to Sanford Health, receiving cash proceeds of $96.1 million. This significantly strengthened the company's balance sheet and resulted in the elimination of $17 million in exchangeable interest related to Black Hills.
Record High Cash Balance
Year-end cash balance reached a record high of $108.5 million, enhancing the company's ability to return capital to shareholders and focus on core assets.
Share Repurchase Program Success
Through substantial issuer bids and normal course issuer bids, MFC repurchased approximately 5.1 million shares, returning $126.2 million to shareholders since 2022.
Recognition of Quality Care
Arkansas Surgical Hospital received the 2024 Press Ganey Human Experience Guardian of Excellence Award for outstanding patient experience, and both Arkansas and Sioux Falls facilities were recognized as top orthopedic hospitals for women.
Negative Updates
Decrease in Facility Service Revenue
Fourth quarter facility service revenue declined by 1.1% to $91.1 million, driven by slightly lower surgical case volumes due to physician absences and a temporary intravenous saline fluid shortage.
Impairment Charge on Goodwill
A $2.3 million impairment charge was recorded against goodwill related to the Newport ASC due to a continued competitive environment and local dynamics.
Increase in Operating Expenses
Consolidated salaries and benefits increased by 4.8% due to higher clinical and non-clinical salaries, annual merit increases, and market wage pressures.
Company Guidance
During the 2024 fourth quarter earnings call for Medical Facilities Corporation, key metrics indicated a robust financial performance and strategic shifts. The company completed the sale of Black Hills to Sanford Health, generating $96.1 million in cash proceeds and eliminating $17 million in exchangeable interest, which significantly bolstered their balance sheet with a record-high cash balance of $108.5 million. Medical Facilities repurchased approximately 1.7 million shares for $16.6 million under their normal course issuer bid and conducted a substantial issuer bid, buying back 3.4 million shares for CAD60.7 million, representing 14.7% of their outstanding shares. Their facility service revenue for the year increased by 1.1% to $331.5 million, while income from operations rose by 10.5% to $54.7 million, and adjusted EBITDA grew by 7.3% to $71.4 million. In the fourth quarter, however, facility service revenue slightly declined by 1.1% to $91.1 million due to lower surgical volumes, which were impacted by physician absences and an industry-wide intravenous saline fluid shortage. Nonetheless, the company maintained a strong focus on shareholder returns, operational excellence, and continued debt reduction, retiring the entire $16 million corporate credit facility balance during the year.

Medical Facilities Financial Statement Overview

Summary
The company exhibits strong profitability with high gross and net profit margins and an impressive ROE. However, the decline in revenue and free cash flow growth is concerning, despite maintaining a stable balance sheet with moderate leverage.
Income Statement
72
Positive
The company shows a strong gross profit margin of 65.8% and a robust net profit margin of 24.7% for TTM. Revenue has decreased by 7.9% over the past year, indicating a contraction. The EBIT margin stands at 18.8%, reflecting a solid operational efficiency, while the EBITDA margin is 25.7%, demonstrating good earnings before non-cash expenses. However, the decline in revenue growth poses a concern.
Balance Sheet
68
Positive
The company maintains a moderate debt-to-equity ratio of 0.88, indicating balanced leverage. The return on equity (ROE) is notably high at 93.7%, which suggests effective use of equity to generate profits. The equity ratio is 27.4%, showing a decent proportion of assets financed by shareholders' equity. Overall, the balance sheet reflects a stable financial position with some leverage.
Cash Flow
75
Positive
The free cash flow has decreased by 10.2% over the past year. The operating cash flow to net income ratio is 0.99, indicating efficient cash generation relative to net earnings. The free cash flow to net income ratio is 0.91, signifying strong cash conversion from profits. Despite the decline in free cash flow, cash flow metrics remain solid.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
304.99M331.53M445.58M424.55M398.63M363.85M
Gross Profit
200.69M219.88M296.68M280.63M268.61M242.94M
EBIT
57.24M61.64M67.11M34.94M77.36M67.79M
EBITDA
78.35M82.57M72.43M51.15M103.40M96.05M
Net Income Common Stockholders
75.45M73.49M18.50M-4.41M15.50M8.81M
Balance SheetCash, Cash Equivalents and Short-Term Investments
65.72M108.50M24.11M34.93M61.04M66.18M
Total Assets
293.85M346.29M354.88M377.79M446.97M457.00M
Total Debt
71.11M73.94M116.81M142.95M140.90M161.95M
Net Debt
5.38M-34.56M92.70M108.03M79.86M95.77M
Total Liabilities
189.13M198.84M236.58M263.10M273.82M281.83M
Stockholders Equity
80.53M122.02M85.99M79.13M127.55M127.53M
Cash FlowFree Cash Flow
68.44M76.22M56.66M50.30M67.22M79.57M
Operating Cash Flow
74.52M83.28M72.71M57.01M75.64M87.09M
Investing Cash Flow
86.41M85.42M-13.67M-5.78M-8.69M18.31M
Financing Cash Flow
-120.71M-84.26M-69.83M-77.35M-72.06M-71.15M

Medical Facilities Technical Analysis

Technical Analysis Sentiment
Positive
Last Price15.85
Price Trends
50DMA
15.34
Positive
100DMA
15.95
Negative
200DMA
15.30
Positive
Market Momentum
MACD
0.07
Negative
RSI
59.67
Neutral
STOCH
46.97
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:DR, the sentiment is Positive. The current price of 15.85 is above the 20-day moving average (MA) of 15.56, above the 50-day MA of 15.34, and above the 200-day MA of 15.30, indicating a bullish trend. The MACD of 0.07 indicates Negative momentum. The RSI at 59.67 is Neutral, neither overbought nor oversold. The STOCH value of 46.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:DR.

Medical Facilities Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
TSEXE
73
Outperform
C$1.18B15.4471.61%3.57%9.38%117.85%
TSDR
73
Outperform
C$297.41M2.3633.87%2.31%-29.54%667.77%
TSSIA
72
Outperform
C$1.70B43.526.93%5.08%8.76%14.05%
61
Neutral
C$176.87M-4.48%-0.69%8.08%
59
Neutral
C$1.02B30.45-3.53%17.19%-191.01%
54
Neutral
$5.38B3.31-45.11%3.29%16.82%0.04%
TSPHA
46
Neutral
C$3.61M-239.50%3.03%-410.90%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:DR
Medical Facilities
15.85
2.88
22.22%
TSE:EXE
Extendicare
14.32
7.13
99.17%
TSE:SIA
Sienna Senior Living
18.70
5.22
38.72%
TSE:CRRX
CareRx
2.86
0.56
24.35%
TSE:WELL
WELL Health Technologies Corp
4.00
-0.20
-4.76%
TSE:PHA
Premier Health of America Inc
0.06
-0.32
-84.21%

Medical Facilities Corporate Events

Executive/Board ChangesShareholder Meetings
Medical Facilities Corporation Announces 2025 Shareholder Meeting Results
Positive
May 8, 2025

Medical Facilities Corporation announced the results of its 2025 Annual Meeting of Shareholders, where all five nominees for the board of directors were elected. Additionally, shareholders approved the appointment of Raymond Chabot Grant Thornton LLP as auditors. This outcome ensures continuity in the company’s leadership and financial oversight, potentially strengthening its operational stability and investor confidence.

Dividends
Medical Facilities Corporation Declares Second Quarter Dividend
Positive
May 8, 2025

Medical Facilities Corporation announced a cash dividend of Cdn $0.09 per common share, payable on July 15, 2025, to shareholders of record as of June 30, 2025. This dividend is designated as an ‘eligible dividend’ under Canadian tax law, potentially benefiting shareholders with favorable tax treatment. The announcement reflects the company’s ongoing commitment to providing shareholder value and may enhance its attractiveness to investors seeking income through dividends.

Stock BuybackBusiness Operations and StrategyFinancial Disclosures
Medical Facilities Corporation Reports Stable Q1 2025 Results and Significant Shareholder Returns
Positive
May 8, 2025

Medical Facilities Corporation reported stable financial results for the first quarter of 2025, with facility service revenue remaining flat at $81.7 million despite one less surgical day. The company saw a 2.2% increase in surgical cases and a slight rise in EBITDA to $17.3 million. A significant highlight was the return of $44.3 million to shareholders through share repurchases, reflecting a strategic focus on capital return. The company’s strong cash position, with $65.7 million in cash and equivalents, supports its ongoing operations and shareholder value initiatives.

Financial Disclosures
Medical Facilities Corporation to Release Q1 2025 Financial Results
Neutral
Apr 24, 2025

Medical Facilities Corporation is set to announce its first quarter 2025 financial results on May 8, 2025, before the market opens. The results will be accessible on SEDAR+ and the company’s website, with an earnings conference call scheduled for the same morning. This announcement is crucial for stakeholders as it provides insights into the company’s financial health and operational performance, potentially impacting its market positioning and investor relations.

Dividends
Medical Facilities Corporation Declares First Quarter Dividend
Positive
Mar 21, 2025

Medical Facilities Corporation has announced a cash dividend of Cdn $0.09 per common share, payable on April 15, 2025, to shareholders of record as of March 31, 2025. This announcement reflects the company’s ongoing commitment to providing shareholder value and may influence investor perceptions positively, reinforcing its stable financial health and strategic positioning in the healthcare industry.

M&A TransactionsStock BuybackBusiness Operations and StrategyFinancial Disclosures
Medical Facilities Corporation Strengthens Financial Position with Strategic Sale and Share Repurchase
Positive
Mar 13, 2025

Medical Facilities Corporation reported its financial results for the fourth quarter and full year 2024, highlighting a strong year marked by the sale of Black Hills Surgical Hospital, which bolstered its financial position. The company ended the year with a cash position of $108.5 million, repurchased shares worth $16.6 million, and fully repaid its corporate credit facility. Despite a slight decline in surgical case volumes due to an industry-wide shortage of intravenous saline fluids, the company achieved growth in income from operations and adjusted EBITDA. The sale of BHSH significantly enhanced the company’s ability to return capital to shareholders and focus on operational excellence and quality care.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.